Business Context and Reporting Period
CareDx, Inc. filed a Form 8-K Current Report on August 31, 2018. The filing discloses the entry into a Material Definitive Agreement to establish an "at-the-market" equity offering program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on the terms of a new financing arrangement.
- Offering Size: Up to $50,000,000 in shares of common stock.
- Sales Agent: Jefferies LLC.
- Commission Rate: 3.0% of gross proceeds from each sale.
- Intended Use of Proceeds: Working capital and general corporate purposes.
Material Changes
The material change reported is the execution of a Sales Agreement on August 31, 2018, authorizing the Company to sell shares through Jefferies LLC. The Company retains the right to suspend offers at any time. The agreement may be terminated by either party with advance written notice.
Guidance, Outlook, and Risks
Outlook: The Company intends to use net proceeds for working capital and general corporate purposes. No specific financial guidance or revenue outlook is provided in this filing.
Risks and Contingencies:
- The Registration Statement on Form S-3 filed on August 31, 2018, has not yet become effective.
- Shares cannot be sold, nor offers accepted, until the Registration Statement is declared effective by the SEC.
- The filing explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy the shares.
Investor Verification Checklist
- Verify the effective date of the Form S-3 Registration Statement to confirm when sales can commence.
- Monitor future filings for actual sales volumes and proceeds generated under the Sales Agreement.
- Review the full text of the Sales Agreement (Exhibit 1.2 to the S-3) for specific termination clauses and expense reimbursement details.
- Check subsequent 10-Q or 10-K filings for the impact of this offering on the Company's capital structure and cash position.